Sunday, May 22, 2022

News

Study: Women face a higher risk for heart failure and heart attack death than men

According to new research published today in the American Heart Association's flagship journal Circulation, women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with...

Moderna applies for FDA authorization for its Covid-19 vaccine

Moderna today announced that the primary efficacy analysis of their Phase 3 study of their vaccine candidate, mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The data analysis indicates a...

Third COVID-19 vaccine, this one from AstraZeneca, up to 90% effective

A third COVID-19 vaccine, this one from AstraZeneca, reported Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease. The results are based on...

FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive results of direct SARS-CoV-2...

Pfizer files with FDA for emergency use of its COVID-19 vaccine in US

Pfizer Inc. and its German partner, BioNTech SE will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable...

Pfizer’s COVID-19 shot 95% effective, seeking FDA clearance soon

In a press release issued today, Pfizer said that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — the last data needed to...

Moderna says its COVID-19 vaccine is 94.5% effective

Moderna said its experimental coronavirus vaccine was nearly 95 percent effective in a pivotal study. The NIH-appointed Data Safety Monitoring Board (DSMB) informed Moderna that the trial has met the statistical criteria pre-specified in the study protocol for...

DoorDash Files IPO, Under Ticker DASH on NYSE

Delivery giant DoorDash Inc. is planning to sell its stock to the public, capitalizing on the growing trend of consumers embracing app-based deliveries with many at home during the pandemic. The company made its...

Major death spikes as the U.S. adds 143,000 COVID-19 cases

Updated data from researchers at John Hopkins University showed 143,200 cases were added on Wednesday, topping the record set the day before by almost 3,000 cases. Wednesday was the fifth single-day case record in nine days.

Analysts predict Pfizer, BioNTech set to make billions in yearly sales with COVID-19 vaccine launch

In a note to clients Tuesday, SVB Leerink analyst Geoffrey Porges said the recent results from Pfizer's early COVID-19 vaccine data should “boost confidence of the general public in COVID vaccines, which should drive up the early adoption rate.” The analysts see Pfizer’s...
- Advertisement -

Latest News

Elon Musk to Acquire Twitter

Twitter, Inc. made it official, it has entered into a definitive agreement to be acquired by an...
- Advertisement -

Renters of color pay higher security deposits, more application fees

Results from Zillow's Consumer Housing Trends Report show renters of color typically submit more applications — and pay more in application fees — before they secure...

FDA investigating illnesses linked to Lucky Charms

The Food and Drug Administration is now investigating why hundreds of consumers have reported becoming ill after eating Lucky Charms cereal.

Inflation, war push stress to alarming levels at the two-year COVID-19 anniversary

Two years after the World Health Organization declared COVID-19 a global pandemic, inflation, money issues and the war in Ukraine have pushed...

Data published in a Lancet journal on novel COVID-19 vaccine shows it produced robust antibodies and T cells against SARS-CoV-2

A COVID-19 investigational vaccine, developed by City of Hope scientists and now licensed to GeoVax Labs Inc., produced a robust neutralizing antibody...